NCT05277415View on ClinicalTrials.gov

Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 17, 2013

Primary Completion Date

May 22, 2014

Study Completion Date

May 22, 2014

Conditions
Heart Failure With Reduced Ejection Fraction HFrEF
Interventions
BIOLOGICAL

Ghrelin

Ghrelin infusion

BIOLOGICAL

Placebo

Placebo

All Listed Sponsors
lead

Lars Lund

OTHER

NCT05277415 - Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure | Biotech Hunter | Biotech Hunter